Pharma Co. Lied About CBD License To Investors, SEC Says

By Jonathan Capriel · October 3, 2022, 4:39 PM EDT

The U.S. Securities and Exchange Commission is going after a pair of pharmaceutical companies that it says lied to potential investors about having exclusive rights to a method for taking CBD...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Securities and Exchange Commission v. Vivera Pharmaceuticals, Inc. et al

Case Number

8:22-cv-01792

Court

California Central

Nature of Suit

Securities/Commodities

Date Filed

September 30, 2022